Hepatology - European Medical Journal

This site is intended for healthcare professionals

Continue

Hepatology

Filter
EMJ
12 Oct 2015

European Liver Patients’ Association (ELPA) Launches Call to Action Report for the Treatment of Hepatic Encephalopathy

BRUSSELS, BELGIUM, 12 October 2015, 18:30 CET – ELPA today launched a new call to action report ‘Time to DeLiver: Getting a Grip on HE’ at the…
EMJ
21 Sep 2015

Gout Medications May Be Effective In Treating Alcohol-Induced Liver Disease

COMMONLY used gout medications could offer protection from alcohol-induced liver disease and inflammation, according to the results of new research in mice.
EMJ
21 Sep 2015

Liver Failure: Stem Cell Therapy Could Replace Liver Transplantation

STEM cell therapy could one day replace liver transplantation as the primary treatment for liver failure, according to a study which saw researchers…
EMJ
22 Jun 2015

New Biomarkers Could Shine Beacon for Personalised Hepatitis C Therapy

BLOOD tests can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy. “While highly effective direct-acting…
EMJ
22 Jun 2015

Starved T Cells Enable Undercover Liver Infection by Hepatitis B

HEPATITIS B has been shown to stimulate processes that deprive the body’s immune cells of key nutrients that they need to function. The findings explain…
16 Jun 2015

Conquering C – Going Beyond Cure

Prof Zeuzem opened the symposium by acknowledging that there is a new era in hepatitis C virus (HCV) treatment, due to the availability of efficacious…
16 Jun 2015

Answering Pivotal Questions in the Diagnosis and Treatment of Primary Biliary Cirrhosis and Non-Alcoholic Steatohepatitis

Professor Trauner introduced the subject of liver disease and its burden within the European Union (EU) and across the globe.
16 Jun 2015

Would You Figure It Out? Differential Diagnoses: Beyond the Usual

The Synageva BioPharma-sponsored symposium discussed the differential diagnoses for liver diseases that may be under-recognised in clinical settings…
We’ve noticed you’re accessing
from North/South America.